多肽CRDMO平台
目录肽
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
SOMA-015A
DOTA-[Tyr3]-Octreotide
DOTA-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (Cys2&Cys7 bridge)
DOTA-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (Cys2&Cys7 bridge)
Size：0.5
P1(RMB)：1073
MW：1405.7
One letter sequence：DOTA-fCFwKTCT-ol (C2&C7 bridge)
Molecular Formula：C65H92N14O17S2
Description：A group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N'N\"N-\"'-tetra-acetate).
Literature Reference：Breeman, W. et al. Int. J. Cancer 104, 376 (2003); Chinol, M. et al. Semin. Nucl. Med. 32,141(2002); De Jong, M. et al. semin Nucl. Med. 32,133(2002).
Cas：
P1(RMB)：1073
MW：1405.7
One letter sequence：DOTA-fCFwKTCT-ol (C2&C7 bridge)
Molecular Formula：C65H92N14O17S2
Description：A group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N'N\"N-\"'-tetra-acetate).
Literature Reference：Breeman, W. et al. Int. J. Cancer 104, 376 (2003); Chinol, M. et al. Semin. Nucl. Med. 32,141(2002); De Jong, M. et al. semin Nucl. Med. 32,133(2002).
Cas：
